Skip to main content
Equibles

Steward Partners Investment Advisory, LLC

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 1723397 STAMFORD, CT
Back to ATNM Full portfolio

Position in ATNM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,960
-$195 QoQ
Shares Held
2,000
-7.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 47 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Steward Partners Investment Advisory, LLC holds $58,588,979 across 162 Biotechnology names. ATNM ranks #128 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VKTX
Viking Therapeutics, Inc.
 351,178 $13,699,453
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 20,851 $10,357,317
3 ARGX
Argenx SE
 9,982 $9,261,000
4 REGN
Regeneron Pharmaceuticals, Inc.
 5,148 $3,209,983
5 BMRN
Biomarin Pharmaceutical Inc
 55,012 $3,147,786
6 CRMD
CorMedix Inc.
 232,615 $1,826,027
7 OCUL
Ocular Therapeutix, Inc
 165,142 $1,621,694
8 NKTR
Nektar Therapeutics
 18,279 $1,276,056

All Filings in ATNM

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,960 2,000
2026-03-31 $2,155 2,166
2025-12-31 $2,945 2,166
2025-09-30 $3,465 2,166
2025-06-30 $2,800 2,000
2025-03-31 $3,220 2,000
2024-12-31 $2,520 2,000
2024-09-30 $3,760 2,000
2024-03-31 $783 100
2023-12-31 $508 100
2023-09-30 $592 100
2023-06-30 $742 100
2022-06-30 $481 100